| Quarter | Score |
|---|---|
| 2022-Q1 | 50.6 |
| 2022-Q3 | 66.9 |
| 2022-Q4 | 49.3 |
| 2023-Q2 | 41.6 |
| 2023-Q3 | 48.8 |
| 2023-Q4 | 36.0 |
| 2024-Q1 | 48.3 |
| 2024-Q2 | 72.1 |
| 2024-Q3 | 87.0 |
| 2024-Q4 | 86.5 |
| 2025-Q1 | 87.2 |
| 2025-Q2 | 85.5 |
| 2025-Q3 | 87.2 |
| 2025-Q4 | 85.1 |
| 2026-Q1 | 87.2 |
| 2026-Q2 | 84.4 |
Solid consensus with smart money net adding at reasonable prices
Within 8.9% of funds' estimated purchase price
2 of 18 tracked funds hold OXY. Avg conviction: 2.2%. Net holding. First tracked at $57.28 (current +8.9% vs tracked).
Berkshire Hathaway has 4.3% in this stock
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Berkshire Hathaway | 4.3% | Hold |
| Citadel Advisors | 0.0% | Add |